Please try another search
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. The company’s lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.
Name | Age | Since | Title |
---|---|---|---|
Garo H. Armen | 70 | 2004 | Co-Founder & Executive Chairman of the Board |
Khalil Barrage | 56 | - | Independent Director |
Robert Benjamin Stein | 70 | 2016 | Chief Medical Officer & Director |
Brian J. Corvese | 64 | 2017 | Independent Director |
Timothy R. Wright | 65 | 2022 | Independent Director |
Jennifer S. Buell | 48 | 2020 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review